Share Twitter LinkedIn Facebook Email Elisha Hughes, Ph.D., Director of Research Biostatistics at Myriad Genetics, Inc. speaks about the SABCS Abstract – P2-11-21 Integration of an ancestrally unbiased polygenic risk score with the Tyrer-Cuzick breast cancer risk model.
Atezolizumab Stumbles in Triple Negative Breast Cancer Study: SABCS 2024 Results with Charles Geyer Breast 4 Mins Read